2022 State Legislative Efforts Bring New Hope For Those Struggling With Infertility
By Ellen Trachman,
Above The Law
| 01. 26. 2022
"GLERL Scientist uses Lab's Inverted Microscope" by
NOAA Great Lakes Environmental Research Laboratory
is licensed under CC BY-NC-ND 2.0
One in eight Americans struggle with infertility. So the chance that you know someone (or are that person) in this situation is approximately 100%. But the price tag for fertility treatment — often $10,000 to $20,000 per attempt at conception through in vitro fertilization (IVF) — keeps the possibility of a child just out of reach for many.
Historically, insurance plans have excluded coverage for infertility, treating it differently than other medical conditions. However, that is slowly changing. Nineteen states (so far) have addressed the issue, and passed an infertility insurance law. This upcoming legislative session, a number of states are looking to continue the trend and increase access to fertility care.
I spoke with Betsy Campbell, chief engagement officer for RESOLVE: The National Infertility Association, about some of the state legislation that they were focused on this year. RESOLVE has worked tirelessly to advocate for better access to fertility care across the country and were instrumental in...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...